Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Ageas, Belgacom, Corio, GBL, UCB: Benelux Equity Market Preview

May 6 (Bloomberg) -- The following companies may have unusual price changes in Benelux markets. Stock symbols are in parentheses, and prices are from the previous close.

The AEX-Index in Amsterdam declined 1.09, or 0.3 percent, to 354.82. Belgium’s Bel20 Index fell 0.3 percent to 2,639.74. The Luxembourg LuxX Index was little changed at 1,417.32.

Dutch stocks:

Corio NV (CORA NA): The largest Dutch property investor said first-quarter earnings before changes in asset values and deferred tax, known as the direct result, increased to 66.2 million euros ($97 million) from 56 million euros a year earlier. Corio advanced 0.3 percent to 47.57 euros.

Belgian stocks:

Ageas (AGS BB): The insurer formerly known as Fortis said it will appeal a ruling by the Rotterdam District Court, which upheld a 576,000-euro fine levied by the Dutch market regulator. Ageas dropped 0.5 percent to 2.01 euros.

Belgacom SA (BELG BB): The largest telephone company in Belgium may say first-quarter net income fell to 191.4 million euros, according to the average of nine analyst estimates compiled by Bloomberg. Belgacom lost 0.2 percent to 26.37 euros.

Groupe Bruxelles Lambert SA (GBLB BB): The Belgian investment firm controlled by billionaires Albert Frere and Paul Desmarais said first-quarter net income fell to 11 million euros and reported net debt of 1.06 billion euros at the end of April. GBL retreated 0.1 percent to 66.61 euros.

UCB SA (UCB BB): The maker of the Cimzia rheumatoid arthritis medicine said Schwarz Vermoegensverwaltung GmbH & Co KG cut its stake to 2.97 percent of voting rights as of April 29 from 4.96 percent on Dec. 9. UCB decreased 0.6 percent to 31.12 euros.

To contact the reporters on this story: John Martens in Brussels at; Fred Pals in Amsterdam at

To contact the editors responsible for this story: Angela Cullen at; Andrew Rummer at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.